Radboud University Medical Centre

Funded with €15.4 million from the EU's Horizon 2020 program, the researchers plan to reanalyze almost 20,000 patient exomes and conduct additional tests on selected subgroups.

One group pointed out differences between study group characteristics, while the other wondered about the role of patient preference.